Latest Coronavirus Disease COVID 19 News and Research
New study initiated to establish the presence of SARS-CoV-2 in environmental samples
he Ministry of Science and Innovation, by way of the COVID-19 fund of the Carlos III Health Institute (ISCIII), is funding a study aimed at establishing the presence of SARS-CoV-2 in environmental samples as well as its indirect transmission potential.
Going global. Scottish online medical specialist signs another international deal with Australian nurse college
Continulus has dramatically widened its global reach with a new collaboration with one of the world’s most highly respected nursing bodies.
How a company misappropriated Native American culture to sell health insurance
Jill Goodridge was shopping for affordable health insurance when a friend told her about O'NA HealthCare, a low-cost alternative to commercial insurance.
Avacta and Medusa19 enter into a distribution agreement for COVID-19 antigen test
Avacta Group plc has entered into an exclusive distribution agreement with Medusa19 Limited for sales of a saliva-based rapid test for the COVID-19 antigen.
Landmark review outlines guidelines for new technologies to facilitate equitable, ethical use of AI
A landmark review of the role of artificial intelligence (AI) in the future of global health published in The Lancet calls on the global health community to establish guidelines for the development and deployment of new technologies and to develop a human-centered research agenda to facilitate equitable and ethical use of AI.
Kids missing measles shots due to coronavirus pandemic
A year ago, the United States saw the highest annual number of measles cases since 1992, with 1,249 cases reported. Of these, 89 percent of the measles patients were unvaccinated or had an unknown vaccination status. Now, fears of another measles outbreak in the country loom as the coronavirus pandemic indirectly is causing a drop in measles vaccinations.
Current antibody tests are good enough to inform decisions about public health, say experts
While it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available today are good enough to inform decisions about public health and relaxing social distancing interventions, says an international group of infectious disease and public health experts in Science Immunology today.
CDC plans nationwide antibody study to determine the magnitude of the coronavirus pandemic
The U.S. Centers for Disease Control and Prevention (CDC) plans to launch a nationwide study to track how the novel coronavirus is spreading across the country.
New insight could help drive cooperative behavior in communities navigating through health crisis
Seeing someone do something good for someone else motivates witnesses to perform their own helpful acts, an insight that could help drive cooperative behavior in communities navigating through the health crisis.
Moderna’s coronavirus vaccine candidate shows promise in phase I trial
Moderna, who partnered with the National Institutes of Health, announced that its candidate vaccine appeared to be safe when administered to eight healthy volunteers. The vaccine also stimulated an immune response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19).
Countries that develop a coronavirus vaccine may not share it, health expert warns
The pandemic has sparked a worldwide race to develop a vaccine against the novel coronavirus. But a health expert has warned that the world might face a risk of "vaccine nationalism," wherein countries who will produce a coronavirus vaccine will not share it with others.
Report describes clinical characteristics and outcomes of children hospitalized with COVID-19
While most children infected with the novel coronavirus have mild symptoms, a subset requires hospitalization and a small number require intensive care.
Loss of smell added to the UK's official list of Covid-19 symptoms
The UK has joined the US, Europe and the World Health Organisation by including loss of smell or taste as an officially recognized symptom of Covid-19 – thanks in part to an international research project involving Professor Carl Philpott at the University of East Anglia.
V-Sensor and e-Checkup-enabled smartphones help monitor vital signs with medical accuracy
The rapid development and deployment of mobile phone apps during the Coronavirus pandemic by governments desperate to find a way to contain the virus by using mobile device technology for tracking and tracing is a clear indicator that mass adoption of smartphones to improve health outcomes in populations is set to become mainstream.
Single Use Surgical donates 5p from every product sold in the UK to Cavell Nurses’ Trust
Single Use Surgical will donate 5p from the sale of every disposable surgical instrument sold in the UK to Cavell Nurses’ Trust to help support the nursing family in their time of need.
New drug treatment can reduce risk of death from COVID-19 infection
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could--if given early enough--potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection.
Prellis Externalized Human Immune System produces human antibodies against SARS-Cov2
Prellis Biologics, Inc. today announced that it has generated 300 human IgG antibodies that bind to either the S1 or S2 spike protein of the SARS-CoV2-Wuhan strain of the novel coronavirus.
Aerosol transmission through new vs. reused N95 masks
The world is grappling with the worst pandemic in over 100 years. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus which emerged in China in December 2019 but has now spread across the globe. With a rapid rate of transmission, SARS-CoV-2 has now affected over 4.88 million people and resulted in over 322,000 deaths.
The use of rheumatoid arthritis drug sarilumab in severe COVID-19 pneumonia
A new study published on the preprint server medRxiv* in May 2020 reports the beneficial effects of the monoclonal antibody sarilumab in severe COVID-19 pneumonia.
Do parasites protect against SARS-CoV-2?
The world has rarely seen such a readily transmissible infection as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) over the last century. Within five months, the virus has created a Tsunami of COVID-19 positive cases, comprising almost 4.88 million people and causing 322,000 deaths.
No hay comentarios:
Publicar un comentario